AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 204 filers reported holding AMICUS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $546,000 | -2.3% | 56,617 | 0.0% | 0.12% | -18.5% |
| Q1 2021 | $559,000 | -57.7% | 56,617 | -1.1% | 0.15% | -66.4% |
| Q4 2020 | $1,322,000 | +63.6% | 57,250 | 0.0% | 0.44% | +137.7% |
| Q3 2020 | $808,000 | -18.5% | 57,250 | -12.9% | 0.18% | -17.9% |
| Q2 2020 | $991,000 | +63.3% | 65,700 | 0.0% | 0.22% | +93.9% |
| Q1 2020 | $607,000 | -5.2% | 65,700 | 0.0% | 0.12% | +134.7% |
| Q4 2019 | $640,000 | +21.4% | 65,700 | 0.0% | 0.05% | +48.5% |
| Q3 2019 | $527,000 | – | 65,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |